Safety and Tolerability of COVID-19 Vaccines in Patients with Cancer: A Single Center Retrospective Analysis

Background: Severe acute respiratory syndrome coronavirus 2 disease (COVID-19) has caused a worldwide challenging and threatening pandemic. Multinational, placebo-controlled, observer-blinded trials were conducted since the beginning of pandemic because safe and effective vaccines were needed urgent...

Descripción completa

Detalles Bibliográficos
Autores principales: Nuzzo, Amedeo, Manacorda, Simona, Sammarco, Enrico, Sbrana, Andrea, Bazzurri, Serena, Paolieri, Federico, Manfredi, Fiorella, Mercinelli, Chiara, Ferrari, Marco, Massaro, Giulia, Bonato, Adele, Salfi, Alessia, Galli, Luca, Morganti, Riccardo, Antonuzzo, Andrea, Cremolini, Chiara, Masi, Gianluca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227366/
https://www.ncbi.nlm.nih.gov/pubmed/35746500
http://dx.doi.org/10.3390/vaccines10060892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227366/
https://www.ncbi.nlm.nih.gov/pubmed/35746500
http://dx.doi.org/10.3390/vaccines10060892

Ejemplares similares